Moore A, McQuay H, Gavaghan D
Oxford Pain Relief Unit, University of Oxford, Oxford Radcliffe Hospital, Headington, UK.
Pain. 1997 Jan;69(1-2):127-30. doi: 10.1016/s0304-3959(96)03251-4.
A previously established relationship for deriving dichotomous from continuous information in randomised controlled trials (RCTs) of analgesics has been tested using an independent data set. Individual patient information from 18 RCTs of parallel-group design in acute postoperative pain (after abdominal, gynaecological and oral surgery) was used to calculate the percentage of the maximum possible pain relief score (%maxTOTPAR) and the proportion of patients with > 50%maxTOTPAR for the different treatments. The relationship between the measures was investigated in 85 treatments with over 3400 patients. In 80 of 85 treatments (94%) agreement between calculated and actual number of patients with > 50%maxTOTPAR was within four patients per treatment and in 72 (85%) was within three (average of 40 patients per treatment, range 21-58 patients). Summing the positive and negative differences between actual and calculated numbers of patients with > 50%maxTOTPAR gave an average difference of 0.30 patients per treatment arm. Reports of RCTs of analgesics frequently describe results of studies in the form of mean derived indices, rather than using discontinuous events, such as number or proportion of patients with 50% pain relief. Because mean data inadequately describe information with a non-normal distribution, combining mean data in systematic reviews may compromise the results. Showing that dichotomous data can reliably be derived from mean data in acute pain studies enables data published as means to be used for quantitative systematic reviews which require data in dichotomous form.
在随机对照试验(RCT)中,从连续信息推导二分信息的先前已确立的关系,已使用独立数据集进行了检验。来自18项急性术后疼痛(腹部、妇科和口腔手术后)平行组设计RCT的个体患者信息,用于计算不同治疗方法的最大可能疼痛缓解评分百分比(%maxTOTPAR)以及%maxTOTPAR>50%的患者比例。在涉及超过3400名患者的85种治疗方法中,研究了这些测量指标之间的关系。在85种治疗方法中的80种(94%)中,计算得出的%maxTOTPAR>50%的患者数量与实际数量之间的差异,在每种治疗方法中不超过4名患者,72种(85%)不超过3名(每种治疗方法平均40名患者,范围为21 - 58名患者)。将%maxTOTPAR>50%的患者实际数量与计算数量之间的正负差异相加,得出每个治疗组的平均差异为0.30名患者。镇痛药RCT的报告经常以平均衍生指标的形式描述研究结果,而不是使用不连续事件,如疼痛缓解50%的患者数量或比例。由于均值数据不能充分描述非正态分布的信息,在系统评价中合并均值数据可能会影响结果。表明在急性疼痛研究中可以从均值数据可靠地推导出二分数据,使得以均值形式发表的数据可用于需要二分形式数据的定量系统评价。